GENFIT : Shareholders Letter 16 - May 2024 marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Lille , Cambridge , Zurich , April 25, 2024 - GENFIT , a late-stage biopharmaceutical company committed to improving the lives of patients with rare, life-threatening liver diseases, today announced.
Lille (France), Cambridge (Massachusetts, USA), Zurich (Switzerland), April 25, 2024 - GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical.